
Cardiovascular Systems, Inc.
Cardiovascular Systems, Inc. is a medical device development company that has completed design, development, and testing of its Orbital Atherectomy Device intended for removal of atherosclerotic blockages in coronary and peripheral arteries.
| Company | Cardiovascular Systems, Inc. |
|---|---|
| URL | http://www.cardiovascularsystemsinc.com/ |
Cardiovascular Systems Signs Merger Agreement
Merger to create NASDAQ-listed medical device company focused on developing and commercializing interventional treatment systems for vascular disease;
St. Paul, MN - Cardiovascular Systems, Inc. (CSI) announced today that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission for a proposed initial public offering of its common stock.
CSI Announces Closing Of $25 Million Financing Round
CSI Announces Closing Of $25 Million Financing Round
Boehringer Ingelheim announced an agreement to acquire Actimis Pharmaceuticals, Inc. one of our portfolio firms.
【Announcement of the Establishment of Beijing Office】
We are pleased to announce that Mitsui Ventures has opened a new office in Beijing in September2007.
Mitsui Ventures Launching a New Approach to Seed Financing
